Revealing praziquantel molecular targets using mass spectrometry imaging: An expeditious approach applied to Schistosoma mansoni

International Journal for Parasitology

Volumn 45, Issue 6, 2015, Pages 385-391

  Ferreira, MÔnica Siqueira ^a   de Oliveira, Rosimeire Nunes ^a   de Oliveira, Diogo Noin ^a   Esteves, Cibele Zanardi ^a   Allegretti, Silmara Marques ^a   Catharino, Rodrigo Ramos ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Biomarkers; Lipids; Mass spectrometry imaging; Praziquantel; Schistosoma mansoni

Indexed keywords

BIOLOGICAL MARKER; PHOSPHOLIPID; PRAZIQUANTEL; ANTHELMINTIC AGENT;

BIOMARKER; DISEASE TREATMENT; DRUG; FLATWORM; LIPID; MASS SPECTROMETRY; SCHISTOSOMIASIS;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG TARGETING; FEMALE; LIPID ANALYSIS; MALE; MASS SPECTROMETRY; METABOLOMICS; MOLECULAR IMAGING; MOUSE; NONHUMAN; SCHISTOSOMIASIS MANSONI; SINGLE DRUG DOSE; ANIMAL; BAGG ALBINO MOUSE; DRUG EFFECTS; PROCEDURES; SCHISTOSOMA MANSONI;

SCHISTOSOMA MANSONI;

ANIMALS; ANTHELMINTICS; BIOMARKERS; FEMALE; MALE; MICE; MICE, INBRED BALB C; MOLECULAR IMAGING; PRAZIQUANTEL; SCHISTOSOMA MANSONI; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 84927003411     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2014.12.008     Document Type: Article

References (59)

1. Abath F.G., Werkhauser R.C. The tegument of Schistosoma mansoni: functional and immunological features. Parasite Immunol. 1996, 18:15-20.
2. Amiri P., Locksley R.M., Parslow T.G., Sadickt M., Rector E., Ritter D., McKerrow J.H. Tumour necrosis factor α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature 1992, 604-607.
3. Andrews P. Praziquantel: mechanisms of anti-schistosomal activity. Pharmacol. Ther. 1985, 29:129-156.
4. Andrieu N., Salvayre R., Levade T. Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor-and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts. Biochem. J. 1994, 303:341-345.
5. Becker B., Mehlhorn H., Andrews P., Thomas H., Eckert J. Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro. Z. Parasitenkd. 1980, 63:113-128.
6. Belka C., Wiegmann K., Adam D., Holland R., Neuloh M., Herrmann F., Krönke M., Brach M. Tumor necrosis factor (TNF)-alpha activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase. EMBO J. 1995, 14:1156.
7. Bligh E., Dyer W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Phys. 1959, 37:911-917.
8. Brouwers J.F., Van Hellemond J.J., van Golde L.M., Tielens A.G. Ether lipids and their possible physiological function in adult Schistosoma mansoni. Mol. Biochem. Parasitol. 1998, 96:49-58.
9. Cornett D.S., Reyzer M.L., Chaurand P., Caprioli R.M. MALDI imaging mass spectrometry: molecular snapshots of biochemical systems. Nat. Methods 2007, 4:828-833.
10. 2+) ATPases of Schistosoma mansoni. Life Sci. 1997, 60:PL289-PL294.
11. Day T., Bennett J., Pax R. Praziquantel: the enigmatic antiparasitic. Parasitol. Today 1992, 8:342-344.
12. de Oliveira D.N., de Bona Sartor S., Ferreira M.S., Catharino R.R. Cosmetic analysis using matrix-assisted laser desorption/ionization mass spectrometry imaging (MALDI-MSI). Materials 2013, 6:1000-1010.
13. Doenhoff M.J., Cioli D., Utzinger J. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr. Opin. Infect. Dis. 2008, 21:659-667.
14. Espinoza B., Silman I., Arnon R., Tarrab-Hazdai R. Phosphatidylinositol-specific phospholipase C induces biosynthesis of acetylcholinesterase via diacylglycerol in Schistosoma mansoni. Eur. J. Biochem. 1991, 195:863-870.
15. Fenwick A., Savioli L., Engels D., Robert Bergquist N., Todd M.H. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends Parasitol. 2003, 19:509-515.
16. Ferreira M.S., de Oliveira D.N., Gonçalves R.F., Catharino R.R. Lipid characterization of embryo zones by silica plate laser desorption ionization mass spectrometry imaging (SP-LDI-MSI). Anal. Chim. Acta 2014, 807:96-102.
17. Ferreira M.S., Oliveira D.N., Oliveira R.N., Allegretti S.M., Vercesi A.E., Catharino R.R. Mass spectrometry imaging: a new vision in differentiating Schistosoma mansoni strains. J. Mass Spectrom. 2014, 49:86-92.
18. Frank S., van Die I., Geyer R. Structural characterization of Schistosoma mansoni adult worm glycosphingolipids reveals pronounced differences with those of cercariae. Glycobiology 2012, 22:676-695.
19. Fried B., Haseeb M.A. Role of lipids in Schistosoma mansoni. Parasitol. Today 1991, 7:204. author reply 204.
20. Furlong S. Unique roles for lipids in Schistosoma mansoni. Parasitol. Today 1991, 7:59-62.
21. Fusco A., Salafsky B., Ellenberger B., Li L.-H. Schistosoma mansoni: correlations between mouse strain, skin eicosanoid production, and cercarial skin penetration. J. Parasitol. 1988, 73:253-261.
22. Garside P., Sands W.A., Kusel J.R., Hagan P. Is the induction of apoptosis the mechanism of the protective effects of TNF-α in helminth infection?. Parasite Immunol. 1996, 18:111-113.
23. Gönnert R., Andrews P. Praziquantel, a new broad-spectrum antischistosomal agent. Z. Parasitenkd. 1977, 52:129-150.
24. Hagan P., Garside P., Kusel J. Is tumour necrosis factor alpha the molecular basis of concomitant immunity in schistosomiasis?. Parasite Immunol. 1993, 15:553-557.
25. Hannun Y.A. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem. 1994, 269:3125-3128.
26. 2+ on the bilayer-isotropic-hexagonal transition of model membranes. Mol. Biochem. Parasitol. 1988, 29:55-59.
27. Hockley D.J., McLaren D.J. Schistosoma mansoni: changes in the outer membrane of the tegument during development from cercaria to adult worm. Int. J. Parasitol. 1973, 3:13-20.
28. Hu W., Brindley P.J., McManus D.P., Feng Z., Han Z.-G. Schistosome transcriptomes: new insights into the parasite and schistosomiasis. Trends Mol. Med. 2004, 10:217-225.
29. Kolesnick R., Golde D.W. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994, 77:325-328.
30. Lima S., Vieira L., Harder A., Kusel J. Effects of culture and praziquantel on membrane fluidity parameters of adult Schistosoma mansoni. Parasitology 1994, 109:57.
31. LoVerde P.T., Hirai H., Merrick J.M., Lee N.H., El-Sayed N. Schistosoma mansoni genome project: an update. Parasitol. Int. 2004, 53:183-192.
32. Machado D., Shishido S.M., Queiroz K.C.S., Oliveira D.N., Faria A.L.C., Catharino R.R., Spek C.A., Ferreira C.V. Irradiated riboflavin diminishes the aggressiveness of melanoma in vitro and in vivo. PLoS One 2013, 8:e54269.
33. Malgat M., Maurice A., Baraud J. Sphingomyelin and ceramide-phosphoethanolamine synthesis by microsomes and plasma membranes from rat liver and brain. J. Lipid Res. 1986, 27:251-260.
34. McLaren D.J. Disguise as an evasive stratagem of parasitic organisms. Parasitology 1984, 88:597-611.
35. Meier H., Blaschke G. Capillary electrophoresis-mass spectrometry, liquid chromatography-mass spectrometry and nanoelectrospray-mass spectrometry of praziquantel metabolites. J. Chrom. B Biomed. Sci. Appl. 2000, 748:221-231.
36. Meier H., Blaschke G. Investigation of praziquantel metabolism in isolated rat hepatocytes. J. Pharm. Biomed. Anal. 2001, 26:409-415.
37. Obeid L.M., Linardic C.M., Karolak L.A., Hannun Y.A. Programmed cell death induced by ceramide. Science 1993, 259:1769-1771.
38. Olivier L., Stirewalt M. An efficient method for exposure of mice to cercariae of Schistosoma mansoni. J. Parasitol. 1952, 38:19-23.
39. Pax R., Bennett J., Fetterer R. A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum. Naunyn Schmiedebergs Arch Pharmacol. 1978, 304:309-315.
40. Pellegrino J., Oliveira C.A., Faria J., Cunha A.S. New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. Am. J. Trop. Med. Hyg. 1962, 11:201.
41. Pica-Mattoccia L., Cioli D. Sex-and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. Int. J. Parasitol. 2004, 34:527-533.
42. Pinlaor S., Prakobwong S., Boonmars T., Wongkham C., Pinlaor P., Hiraku Y. Effect of praziquantel treatment on the expression of matrix metalloproteinases in relation to tissue resorption during fibrosis in hamsters with acute and chronic Opisthorchis viverrini infection. Acta Trop. 2009, 111:181-191.
43. Raines M., Kolesnick R., Golde D. Sphingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J. Biol. Chem. 1993, 268:14572-14575.
44. Redman C., Robertson A., Fallon P., Modha J., Kusel J., Doenhoff M., Martin R. Praziquantel: an urgent and exciting challenge. Parasitol. Today 1996, 12:14-20.
45. Redman C.A., Kennington S., Spathopoulou T., Kusel J.R. Interconversion of sphingomyelin and ceramide in adult Schistosoma mansoni. Mol. Biochem. Parasitol. 1997, 90:145-153.
46. Rodrigues L.R., Oliveira D.N.D., Ferreira M.S., Catharino R.R. In situ assessment of atorvastatin impurity using MALDI mass spectrometry imaging (MALDI-MSI). Anal. Chim. Acta 2014, 818:32-38.
47. Sabah A., Fletcher C., Webbe G., Doenhoff M. Schistosoma mansoni: chemotherapy of infections of different ages. Exp. Parasitol. 1986, 61:294-303.
48. Shaw J., Marshall I., Erasmus D. Schistosoma mansoni. In vitro stimulation of vitelline cell development by extracts of male worms. Exp. Parasitol. 1977, 42:14-20.
49. Smith T.M., Brooks T.J. Lipid fractions in adult Schistosoma mansoni. Parasitology 1969, 59:293-298.
50. Solon E.G. Autoradiography: high-resolution molecular imaging in pharmaceutical discovery and development. Expert Opin. Drug Discov. 2007, 2:503-514.
51. Tallima H., El Ridi R. Praziquantel binds Schistosoma mansoni adult worm actin. Int. J. Antimicrob. Agents 2007, 29:570-575.
52. Testi R. Sphingomyelin breakdown and cell fate. Trends Biochem. Sci. 1996, 21:468-471.
53. Troiani A.R., Pica-Mattoccia L., Valle C., Cioli D., Mignogna G., Ronketti F., Todd M. Is actin the praziquantel receptor?. Int. J. Antimicrob. Agents 2007, 30:280-281.
54. Urayama S., Zou W., Brooks K., Tolstikov V. Comprehensive mass spectrometry based metabolic profiling of blood plasma reveals potent discriminatory classifiers of pancreatic cancer. Rapid Commun. Mass Spectrom. 2010, 24:613-620.
55. van Balkom B.W., van Gestel R.A., Brouwers J.F., Krijgsveld J., Tielens A.G., Heck A.J., van Hellemond J.J. Mass spectrometric analysis of the Schistosoma mansoni tegumental sub-proteome. J. Prot. Res. 2005, 4:958-966.
56. Webbe G., James C. A comparison of the susceptibility to praziquantel of Schistosoma haematobium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei in hamsters. Z. Parasitenkd. 1977, 52:169-177.
57. Wiest P.M., Burnham D.C., Olds G.R., Bowen W.D. Developmental expression of protein kinase C activity in Schistosoma mansoni. Am. J. Trop. Med. Hyg. 1992, 46:358-365.
58. You H., McManus D.P., Hu W., Smout M.J., Brindley P.J., Gobert G.N. Transcriptional responses of in vivo praziquantel exposure in schistosomes identifies a functional role for calcium signalling pathway member CamKII. PLoS Pathol. 2013, 9:e1003254.
59. Young B.W., Podesta R.B. Major phospholipids and phosphatidylcholine synthesis in adult Schistosoma mansoni. Mol. Biochem. Parasitol. 1982, 5:165-172.